LeMaitre Vascular, Inc.
LMAT
$79.47
-$0.12-0.15%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 9.57% | 11.16% | 15.68% | 11.36% | 15.01% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.57% | 11.16% | 15.68% | 11.36% | 15.01% |
| Cost of Revenue | 1.87% | -1.60% | 6.63% | 0.85% | 10.80% |
| Gross Profit | 12.87% | 16.84% | 19.69% | 16.35% | 16.91% |
| SG&A Expenses | 0.90% | 7.54% | 7.72% | 20.12% | 27.71% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.94% | 3.24% | 6.43% | 9.27% | 15.97% |
| Operating Income | 26.37% | 40.78% | 46.51% | 17.98% | 12.25% |
| Income Before Tax | 22.79% | 38.14% | 44.78% | 55.13% | 16.54% |
| Income Tax Expenses | 19.76% | 23.62% | 66.30% | 52.82% | 16.60% |
| Earnings from Continuing Operations | 23.74% | 42.39% | 39.32% | 55.84% | 16.51% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 23.74% | 42.39% | 39.32% | 55.84% | 16.51% |
| EBIT | 26.37% | 40.78% | 46.51% | 17.98% | 12.25% |
| EBITDA | 22.73% | 34.39% | 40.39% | 16.38% | 12.09% |
| EPS Basic | 22.42% | 40.93% | 38.10% | 54.57% | 15.70% |
| Normalized Basic EPS | 21.49% | 36.71% | 47.25% | 21.16% | 15.74% |
| EPS Diluted | 22.63% | 41.67% | 41.37% | 53.61% | 15.38% |
| Normalized Diluted EPS | 14.60% | 37.33% | 48.20% | 14.36% | 15.66% |
| Average Basic Shares Outstanding | 1.08% | 1.02% | 0.90% | 0.82% | 0.69% |
| Average Diluted Shares Outstanding | 7.16% | 0.58% | 0.29% | 6.81% | 0.73% |
| Dividend Per Share | 25.00% | 25.00% | 25.00% | 25.00% | 25.00% |
| Payout Ratio | 0.02% | -0.11% | -0.10% | -0.19% | 0.08% |